Kalorama Medical Device Bundle (Infusion Pumps, Reusable Devices, Minimally Invasive Surgical Devices, Catheters, OEM Finished Medical Products)

Table of Contents

INFUSION PUMP MARKETS

CHAPTER ONE: EXECUTIVE SUMMARY

• Overview and Scope of Study
• Size and Growth of the Market
• Key Issues and Trends Affecting Market

CHAPTER TWO: INTRODUCTION AND TRENDS SHAPING THE MARKET

• Overview
• Types of Infusion and Pumps
• Applications
  • Hospital Inpatient Care
  • Assisted Living, Hospice, Home Healthcar
  • Military Applications
• Infusion Pumps and Reducing Medication Errors
• Reducing Errors in Hospitals with Bar Codes
• Health Risks Associated with Infusion Pump Use
• Infection
• Phlebitis
• Infiltration/Extravasation
• Occlusion
• Electrolyte Imbalance
• Air Embolism
• Fluid Overload
• Infusion Pumps and Recalls
• Increasing Life Expectancy and the Growing Demand for Innovative Products
• World Demographics
• Incidence, Prevalence of Disease: United States
• Worldwide Spending on Healthcare
• Reducing Hospital Inpatient Length of Stay – Steady Increase for Home Health Services

CHAPTER THREE: GENERAL PURPOSE INFUSION PUMPS

• Overview of Products
• Large Volume Infusion Pumps
  • Key Products, Manufacturers and Recent Developments
  • Baxter International
  • Cardinal Health
  • Definitive Medical Technologies
  • Fresenius Kabi
  • Hospira
  • Smiths Medical
  • Zyno Medical
  • Market Summary
  • Competitive Summary

Ambulatory Infusion Pumps

• Key Products, Manufacturers and Recent Developments
• Advanced Infusion
• Baxter International
• Caesarea Medical Electronics
• Curlin Medical
• Fresenius Kabi
• Hospira
• I-Flow
• Nipro Medical/Europe
• Sorenson Medical
• Smiths Medical
• Symbios Medical
• Universal Medical Technologies
• Market Summary
• Competitive Summary

Syringe Infusion Pumps

• Key Products, Manufacturers and Recent Developments
• Baxter International
• Cardinal Health
• Caesarea Medical Electronics
• Excelsior Medical
• Fresenius Kabi
• Hospira
• Smiths Medical
• Market Summary
• Competitive Summary

CHAPTER FOUR: SPECIALTY INFUSION PUMPS

• Overview
• Enteral Feeding Pumps
  • Key Products, Manufacturers and Recent Developments
  • Abbott Laboratories
  • Caesarea Medical Electronics
  • Covidien
  • Fresenius Kabi
  • Nestle Nutrition
  • Zevex
  • Market Summary
  • Competitive Summary
• Insulin Infusion Pumps
  • Key Products, Manufacturers, and Recent Developments
  • Animas Corporation
  • Insulet Corporation
  • Medtronic
  • Nipro Diabetes Systems
  • Roche Diabetes Care
  • Smiths Medical
  • Sooil Development
  • Market Summary
  • Competitive Summary
• Implantable Infusion Pumps
  • Key Products, Manufacturers and Recent Developments
  • Medtronic
  • Market Summary
  • Competitive Summary

CHAPTER FIVE TOTAL MARKET ANALYSIS

• Market Overview
• General Purpose Infusion Pump Market Analysis
• Specialty Infusion Pump Market Analysis

CHAPTER SIX: LEADING MANUFACTURERS

• Overview
• Alaris/Cardinal Health
• Animas/Johnson & Johnson
• B. Braun
• Baxter
• Fresenius Kabi
• Hospira
• Insulet
• IRadimed
• Kendall/Covidien
• MiniMed/Medtronic
• Smiths Group
• Zevex/Moog

CHAPTER SEVEN: LIST OF MAJOR COMPANIES

LIST OF EXHIBITS

CHAPTER ONE: EXECUTIVE SUMMARY

• Table 1-1: Worldwide Infusion Pump Market Analysis, 2005-2007
• Table 1-2: Worldwide Infusion Pump Market Analysis: 2008-2012
• Figure 1-1: Worldwide Infusion Pump Market Analysis: 2005-2012

CHAPTER TWO: INTRODUCTION

• Table 2-1: Registered Hospitals and Acute Care Centers by Country
• Figure 2-1: Number of Hospitals in the US, 1975-2007
• Table 2-2: U.S. Registered Hospitals by Type, 2007
• Table 2-3: Leading For-Profit U.S. Hospital Chains, 2007
• Table 2-4: Leading Assisted Living Groups, 2006/2007 (United States)
• Figure 2-2: Number of Nursing Homes, 2000-2005
• Figure 2-3: Growth in Hospice Programs in the United States, 1997-2006
• Figure 2-4: Patients Served with Hospice Programs in the United States, 1997-2006
• Table 2-5: Percentage of Hospice Admissions by Primary Diagnosis, 2005 and 2006
• Table 2-6: US Food and Drug Administration Infusion Pump Recalls 2008 (partial)
• Table 2-7: Average Life Expectancy in Years by Country 1980 and 2006
• Figure 2-5: Average Life Expectancy in Years by Country 1980 and 2006
• Table 2-8: World Population by Selected Geographical Region, 2007 – 2050
• Figure 2-6: World Population by Selected Geographical Region, 2007-2050
• Table 2-9: Estimated World Population by Age and Geographical Region, 2007
• Figure 2-7: Estimated World Population by Age and Geographical Region, 2007
• Table 2-10: Percent Population Over 65 by Year and Region
• Figure 2-8: Estimated World Population by Age, 2007 and 2050
• Table 2-11: U.S. Prevalence of Selected Medical Conditions
• Figure 2-9: U.S. Prevalence of Selected Medical Conditions
• Figure 2-10: US Healthcare Spending, 2000-2015 (in billions)
• Figure 2-11: Length of Service Days for Hospice Patients in the United States, 2001-2006

CHAPTER THREE: GENERAL PURPOSE INFUSION PUMPS

• Table 3-1: Selected Large Volume Infusion Pumps
• Table 3-2: Large Volume Infusion Pump Market Analysis, 2005-2007
• Table 3-3: Large Volume Infusion Pump Market Analysis, 2008-2012
• Figure 3-1: Large Volume Infusion Pump Market Analysis, 2005-2012
• Table 3-4: Large Volume Infusion Pump Market Estimated Revenues and Market Share of Leading Suppliers 2007
• Figure 3-2: Large Volume Infusion Pump Market Estimated Market Share by Leading Suppliers 2007
• Table 3-5:Selected Ambulatory Infusion Pumps
• Table 3-6: Ambulatory Infusion Pump Market Analysis, 2005-2007
• Table 3-7: Ambulatory Infusion Pump Market Analysis, 2008-2012
• Figure 3-3: Ambulatory Infusion Pump Market Analysis, 2005-2012
• Table 3-8: Ambulatory Infusion Pump Market Estimated Revenues and Market Share of Leading Suppliers 2007
• Figure 3-4: Ambulatory Infusion Pump Market Estimated Market Share by Leading Suppliers 2007
• Table 3-9: Selected Syringe Infusion Pumps
• Table 3-10: Syringe Infusion Pump Market Analysis, 2005-2007
• Table 3-11: Syringe Infusion Pump Market Analysis, 2008-2012
• Figure 3-5: Syringe Infusion Pump Market Analysis, 2005-2012
• Table 3-12: Syringe Infusion Pump Market Estimated Revenues and Market Share of Leading Suppliers 2007
• Figure 3-6: Syringe Infusion Pump Market Estimated Market Share by Leading Suppliers 2007

CHAPTER FOUR SPECIALTY PUMPS

• Table 4-1: Selected Enteral Feeding Pumps
• Table 4-2: Enteral Feeding Pump Market Analysis, 2005-2007
• Table 4-3: Enteral Feeding Pump Market Analysis, 2008-2012
• Figure 4-1: Enteral Feeding Pump Market Analysis, 2005-2012
• Table 4-4: Enteral Feeding Pump Market Estimated Revenues and Market Share of Leading Suppliers 2007
• Figure 4-2: Enteral Feeding Pump Market Estimated Market Share by Leading Suppliers 2007
• Table 4-5: Selected Insulin Infusion Pumps
• Table 4-6: Insulin Infusion Pump Market Analysis, 2005-2007
• Table 4-7: Insulin Infusion Pump Market Analysis, 2008-2012
• Figure 4-3: Insulin Infusion Pump Market Analysis, 2005-2012
• Table 4-8: Insulin Infusion Pump Market Estimated Revenues and Market Share of Leading Suppliers 2007
• Figure 4-4: Insulin Infusion Pump Market Estimated Market Share by Leading Suppliers 2007
• Table 4-9: Implantable Infusion Pump Market Analysis, 2005-2007
• Table 4-10: Implantable Infusion Pump Market Analysis, 2008-2012
• Figure 4-5: Implantable Infusion Pump Market Analysis, 2005-2012

CHAPTER FIVE: TOTAL INFUSION PUMP MARKETS

• Table 5-1: Worldwide Infusion Pump Market Analysis, 2005-2007
• Table 5-2: Worldwide Infusion Pump Market Analysis: 2008-2012
• Figure 5-1: Worldwide Infusion Pump Market Analysis: 2005-2012
• Table 5-3: Worldwide General Purpose Infusion Pump Market Analysis by Product Type, 2005-2007
• Table 5-3: Worldwide General Purpose Infusion Pump Market Analysis by Product Type, 2008-2012
• Table 5-4: Worldwide General Purpose Infusion Pump Market Analysis by Product Type, 2005-2012
• Figure 5-3: Worldwide General Purpose Infusion Pump Market Share by Product Type, 2007 and 2012
• Table 5-5: Worldwide Specialty Infusion Pump Market Analysis by Product Type, 2005-2007
• Table 5-6: Worldwide Specialty Infusion Pump Market Analysis by Product Type, 2008-2012
• Table 5-7: Worldwide Specialty Infusion Pump Market Analysis by Product Type, 2005-2012
• Figure 5-6: Worldwide Specialty Infusion Pump Market Share by Product Type, 2007 and 2012 108

CHAPTER SIX: LEADING MANUFACTURER PROFILES

• Figure 6-1: Cardinal Health’s Net Revenues for 2005, 2006, and 2007 111
• Figure 6-2: Johnson & Johnson’s Net Revenues for 2005, 2006, and 2007 113
• Figure 6-3: B. Braun’s Net Revenues for 2005, 2006, and 2007 115
• Figure 6-4: Baxter’s Net Revenues for 2005, 2006, and 2007 118
• Figure 6-5: Fresenius’s Net Revenues for 2005, 2006, and 2007 120
• Figure 6-6: Hospira’s Net Revenues for 2005, 2006, and 2007 123
• Figure 6-7: I-Flow’s Net Revenues for 2005, 2006, and 2007 125
• Figure 6-8: I-Flow’s Net Revenues for 2005, 2006, and 2007 127
• Figure 6-9: Covidien’s Net Revenues for 2005, 2006 and 2007 131
• Figure 6-10: Medtronic’s Net Revenues for 2006, 2007 and 2008 134
• Figure 6-11: Smiths Group’s Net Revenues for 2005*, 2006 and 2007 137
• Figure 6-12: Moog’s Net Revenues for 2005, 2006 and 2007 139

REUSABLE DEVICE MARKETS

TABLE OF CONTENTS

CHAPTER ONE: EXECUTIVE SUMMARY

• Overview
• Scope and Methodology
• Size and Growth of the Market
• Issues and Trends
• Leading Competitor

CHAPTER TWO: INTRODUCTION

• Overview of Reusable Medical Instruments and Devices
• Demographics
• Population Over Age 65
• Life Expectancy
• Incidence of Diseases
• Healthcare Facilities
• Regulatory Overview
• Environmental Concerns

CHAPTER THREE: CARDIOVASCULAR SURGICAL PRODUCTS

• Overview and Product Description
• Key Manufacturers and Products
• Procedure Volumes
• Leading Competitors
• Market Summary

CHAPTER FOUR: EAR, NOSE, AND THROAT SURGICAL PRODUCTS

• Overview and Product Description
• Key Manufacturers and Products
• Procedure Volumes
• Leading Competitors
• Market Summary

CHAPTER FIVE: NEUROSURGICAL PRODUCTS

• Overview
• Key Manufacturers and Products
• Procedure Volumes
• Market Summary

CHAPTER SIX: ORTHOPEDIC SURGICAL PRODUCTS

• Overview
• Key Manufacturers and Products
• Procedure Volumes
• Leading Competitors
• Market Summary

CHAPTER SEVEN: UROLOGICAL AND GYNECOLOGICAL SURGICAL PRODUCTS

• Overview
• Key Manufacturers and Products
• Procedure Volumes
• Leading Competitors
• Market Summary

CHAPTER EIGHT: PLASTIC, COSMETIC AND RECONSTRUCTIVE SURGICAL PRODUCTS

• Overview
• Key Manufacturers and Products
• Procedure Volumes
• Leading Competitors
• Market Summary

CHAPTER NINE: OPHTHAMALIC SURGICAL PRODUCTS

• Overview
• Key Manufacturers and Products
• Procedure Volumes
• Leading Competitors
• Market Summary

CHAPTER TEN: GENERAL SURGICAL PRODUCTS

• Overview
  • Upper Digestive Tract Procedures
  • Lower Digestive Tract Procedures
• Key Manufacturers and Products
• Procedure Volumes
• Leading Competitors
• Market Summary

CHAPTER ELEVEN: ISSUES AND TRENDS

• Overview
• Environmental Issues
  • OSHA Regulations
  • US EPA Regulations
  • DOT Regulations
• Sterilizing Issues and Trends

CHAPTER TWELVE: TOTAL MARKET SIZE AND FORECAST

• Summary
• Market Analysis by Discipline

CHAPTER THIRTEEN: CORPORATE PROFILES

• Aesculap
• ArthroCare Corporation
• Cardinal Health Inc.
• Conmed Corporation
• Covidien Ltd.
• Integra Life Sciences, Inc.
• Karl Storz GmbH & Co. KG
• Kinamed Incorporated
• Mediflex Surgical Products
• Medtronic, Inc
• Stryker Corporation
• Vision Sciences Inc

REGULATORY AUTHORITIES AND ORGANIZATIONS

LIST OF KEY COMPANIES

TABLE OF EXHIBITS

CHAPTER ONE: EXECUTIVE SUMMARY

• Table 1-1: Total U.S. Market for Reusable Medical Instruments and Devices, 2005-2012
• Figure 1-1: Total U.S. Market for Reusable Medical Instruments and Devices, 2005-2012

CHAPTER TWO: INTRODUCTION

• Table 2-1: The U.S. Population, 1980-202
• Figure 2-1: The US Population, 1980-2020
• Figure 2-2: Estimated Population by Age Group, 2000 and 2050
• Table 2-3: Average U.S. Life Expectancy in Years 1980, 2004 and 2006
• Figure 2-3: Average U.S. Life Expectancy in Years 1980 and 2006
• Table 2-4: U.S. Prevalence of Selected Medical Conditions
• Figure 2-4: U.S. Prevalence of Selected Medical Conditions
• Table 2-5: U.S. Registered Hospitals by Type, 2006
• Table 2-6: Physicians in the US by Specialty, 1970-2000

CHAPTER THREE: CARDIOVASCULAR SURGICAL PRODUCTS

• Table 3-1: U.S. Procedure Volumes for Cardiovasc`ular Surgery*
• Table 3-2: Leading Cardiovascular Instrument and Device Manufacturers, 2007
• Table 3-3: Reusable Medical Instrument and Device Market for Cardiovascular Surgery, 2005-2012
• Figure 3-1: Reusable Medical Instrument and Device Market for Cardiovascular Surgery, 2005-2012

CHAPTER FOUR: EAR, NOSE, AND THROAT SURGICAL PRODUCT

• Table 4-1: U.S. Procedure Volumes for ENT*
• Table 4-2: Leading Ear, Nose and Throat Instrument Manufacturers, 2007
• Table 4-3: Reusable Medial Instruments and Devices for ENT Procedures, 2005-2012
• Figure 4-1: Reusable Medial Instruments and Devices for ENT Procedures, 2005-2012

CHAPTER FIVE: NEUROSURGICAL PRODUCTS

• Table 5-1: U.S. Procedure Volumes for Neurosurgery*
• Table 5-2: Leading Neurological manufacturers, 2007
• Table 5-3: Reusable Medical Instrument and Device Market for Neurosurgery, 2005-2012
• Figure 5-1: Reusable Medical Instrument and Device Market for Neurosurgery, 2005-2012

CHAPTER SIX: ORTHOPEDIC SURGICAL PRODUCTS

• Table 6-1: U.S. Procedure Volumes for Orthopedic Surgery*
• Table 6-2: Leading Orthopedic Manufacturers, 2007
• Table 6-3: Reusable Medical Instruments and Devices for Orthopedic Procedures, 2005-2012
• Figure 6-1: Reusable Medical Instruments and Devices for Orthopedic Procedures, 2005-2012

CHAPTER SEVEN: UROLOGICAL AND GYNECOLOGICAL SURGICAL PRODUCTS

• Table 7-1: U.S. Procedure Volumes for Urological and Gynecological*
• Table 7-2: Leading Urological and Gynecological Manufacturers, 2007
• Table 7-3: Reusable Medical Instruments and Devices for Urological and Gynecological Surgical Procedures, 2005-2012
• Figure 7-1: Reusable Medical Instruments and Devices for Urological and Gynecological Surgical Procedures, 2005-2012

CHAPTER EIGHT: PLASTIC, COSMETIC AND RECONSTRUCTIVE SURGICAL PRODUCTS

• Table 8-1: U.S. Procedure Volumes for Plastic, Cosmetic and Reconstructive* Surgery
• Table 8-2: U.S. Procedure Volumes by year for Plastic, Cosmetic and Reconstructive from 1997-2007
• Table 8-3: Leading Plastic, Cosmetic and Reconstructive Reusable Medical Instruments and Devices Manufacturers, 2007
• Table 8-4: Reusable Medical Instruments and Devices for Plastic, Cosmetic, and Reconstructive Surgical Procedures, 2005-2012
• Figure 8-1: Reusable Medical Instruments and Devices for Plastic, Cosmetic, and Reconstructive Surgical Procedures, 2005-2012 CHAPTER NINE: OPHTHAMALIC SURGICAL PRODUCTS
• Table 9-1: Prevalence of Cataract, Age-Related Macular Degeneration, and Open-Angle Glaucoma in Adults 40 Years and Older in the United States, 2004
• Table 9-2: Prevalence of Diabetic Retinopathy in Adults, 2004
• Table 9-3: Prevalence of Blindness and Low Vision in Adults 40 Years and Older in the United States, 2004
• Table 9-4: Estimated Prevalence of Myopia and Hyperopia, 2004
• Table 9-5: U.S. Procedure Volumes for Ophthalmic Surgery
• Table 9-6: Leading Ophthalmalic Manufacturers, 2007
• Table 9-7: Reusable Medical Instruments and Devices for Ophthalmic Surgical Procedures
• Figure 9-1: Reusable Medical Instruments and Devices for Ophthalmic Surgical Procedures

CHAPTER TEN: GENERAL SURGICAL PRODUCTS

• Table 10-1: U.S. Volumes for General Surgery*
• Table 10-2: Leading General Surgery Manufacturers, 2007
• Table 10-3: Reusable Medical Instruments and Devices for General Surgery, 2005-2012
• Figure 10-1: Reusable Medical Instruments and Devices for General Surgery, 2005-2012

CHAPTER ELEVEN: ISSUES AND TRENDS

• Table 11-1: U.S. Totals of Regulated Medical Waste in Hospitals and other Medical Facilities
• Table 11-2: Hospital Regulated Medical Waste in the U.S.
• Table 11-3: U.S. Hospital/Medical Infectious Waste Incinerator Use Timeline
• Table 11-4: State Comparison of Regulated Medical Waste Environment
• Table 11-5: Levels of Disinfections in US*
• Table 11-6: Commonly Used Steam Sterilization Cycles
• Table 11-7: Commonly Used Ethylene Oxide (EtO) Sterilization Cycles
• Table 11-8: Commonly Used Liquid Chemical Sterilants
• Table 11-9: Commonly Used Chemical Sterilant Gases

CHAPTER TWELVE: TOTAL MARKET SIZE AND FORECAST

• Table 12-1: Total U.S. Market for Reusable Medical Instruments and Devices, 2005-2012
• Figure 12-1: Total U.S. Market for Reusable Medical Instruments and Devices, 2005-2012
• Figure 12-2: Reusable Medical Instruments and Devices by Discipline, 2007
• Figure 12-3: Reusable Medical Instruments and Devices by Discipline, 2012
• MINIMALLY INVASIVE SURGICAL DEVICE MARKETS
• CHAPTER ONE: EXECUTIVE SUMMARY
• Introduction
• Scope and Methodology
• Size and Growth of the Market
• Key Issues and Trends Affecting the Market
• Leading Competitors
• CHAPTER TWO: INTRODUCTION
• Overview
• World Demographics
• Description of MIS Procedures
• Orthopedic
• Neurosurgery
• Otorhinolaryngology and Respiratory
• Cardiovascular
• Gastrointestinal
• Urology and Gynecology
• Product Categories
• Endoscopes
• Design of Endoscopes
• Cameras and Video Support
• Hand Instruments
• Electrosurgical and Radiofrequency Instruments
• Insufflators
• Power Surgical Instruments
• Lasers
• Other (disposables)
• Distribution, Sales and Marketing
• Medical Applications
• Orthopedic
• Neurosurgery
• Ear, Nose, and Throat and Respiratory
• Cardiovascular
• Heart Valve Surgery
• Coronary Artery Bypass Graph Surgery (CABG)
• Gastrointestinal System
• Upper Gastrointestinal Tract Procedures
• Lower Gastrointestinal Tract Procedures
• Urological and Gynecological
• Advantages of Minimally Invasive Surgery
• Disadvantages of Minimally Invasive Surgery
• CHAPTER THREE: ISSUES AND TRENDS
• Overview
• Training and Education
• Cost and Reimbursement
• Natural Orifice Translumenal Endoscopic Surgery
• Obesity
• Robotics and MIS
• The MIS Solution
• Materials Industry Concerns
• Hospital- Acquired Infection
• CHAPTER FOUR: ORTHOPEDIC DEVICES
• Introduction
• Procedure Volumes
• Products
• Market Size and Forecast
• Market Analysis by Country
• Leading Competitors
• CHAPTER FIVE: NEUROSURGERY DEVICES
• Introduction
• Procedure Volumes
• Products
• Market Size and Forecast
• Market Analysis by Country
• Leading Competitors
• CHAPTER SIX: ENT AND RESPIRATORY DEVICES
• Introduction
• Procedure Volumes
• Products
• Market Size and Forecast
• Market Analysis by Country
• Leading Competitors
• CHAPTER SEVEN: CARDIOVASCULAR DEVICES
• Introduction
• Procedure Volumes
• Products
• Market Size and Forecast
• Market Analysis by Country
• Leading Competitors
• CHAPTER EIGHT: GASTROINTESTINAL SYSTEM DEVICES
• Introduction
• Procedure Volumes
• Products
• Market Size and Forecast
• Market Analysis by Country
• Leading Competitors
• CHAPTER NINE: UROLOGICAL AND GYNECOLOGICAL DEVICES
• Introduction
• Procedure Volumes
• Products
• Market Size and Forecast
• Market Analysis by Country
• Leading Competitors
• CHAPTER TEN: TOTAL MARKET SIZE AND FORECAST
• Total Market Overview
• Minimally Invasive Surgery Market by Application
• U.S. Market Size
• Europe Market Size
• Rest of World Market Size
• Leading Competitors
• CHAPTER ELEVEN: CORPORATE PROFILES
• Overview
• Aesculap Division
• Boston Scientific Corporation
• Conmed Corporation
• Covidien Ltd
• Given Imaging, Ltd.
• Johnson & Johnson, Inc
• Karl Storz GmbH & Co. KG
• Medtronic, Inc
• Olympus Corporation
• Smith & Nephew, Plc
• Stryker Corporation
• APPENDIX A: LIST OF MAJOR COMPANIES
• LIST OF EXHIBITS
• CHAPTER ONE: EXECUTIVE SUMMARY
• Table 1-1: Minimally Invasive Surgery: Total Market Analysis, 2005-2007
• Table 1-2: Minimally Invasive Surgery: Total Market Analysis: 2008-2012
• Figure 1-1: Minimally Invasive Surgery: Total Market Analysis: 2005-2012
• CHAPTER TWO: INTRODUCTION
• Table 2-1: World Population by Selected Geographical Region, 2007 – 2050
• Figure 2-1: World Population by Selected Geographical Region, 2007-2050
• Table 2-2: Estimated World Population by Age and Geographical Region, 2007
• Figure 2-2: Estimated World Population by Age and Geographical Region, 2007
• Table 2-3: Percent Population Over 65 by Year and Region
• Figure 2-3: Estimated World Population by Age, 2007 and 2050
• CHAPTER THREE: ISSUES AND TRENDS
• Table 3-1: Selected MIS Procedures Reimbursement Comparison 2007, 2008
• CHAPTER FOUR: ORTHOPEDIC DEVICES
• Table 4-1: U.S. and Europe Procedure Volumes for Orthopedic Surgery*
• Figure 4-1: U.S. and Europe Procedure Volumes for Orthopedic Surgery*
• Table 4-2: MIS: Orthopedic Market Analysis, 2005-2007
• Table 4-3: MIS: Orthopedic Market Analysis: 2008-2012
• Figure 4-2: MIS: Orthopedic Market Analysis: 2005-2012
• Table 4-4: MIS: Orthopedic Market Analysis by Region/Country, 2007
• Figure 4-3: MIS: Orthopedic Market Analysis by Region/Country, 2007
• Table 4-5: Leading MIS Orthopedic Instrument and Equipment Suppliers, 2007
• CHAPTER FIVE: NEUROSURGERY DEVICES
• Table 5-1: U.S. and Europe Procedure Volumes for Neurosurgery*
• Figure 5-1: U.S. and Europe Procedure Volumes for Neurosurgery
• Table 5-2: MIS: Neurosurgery Market Analysis, 2005-2007
• Table 5-3: MIS: Neurosurgery Market Analysis: 2008-2012
• Figure 5-2: MIS: Neurosurgery Market Analysis: 2005-2012
• Table 5-4: MIS: Neurosurgery Market Analysis by Region/Country, 2007
• Figure 5-3: MIS: Neurosurgery Market Analysis by Region/Country, 2007
• Table 5-5: Leading MIS Neurosurgery Instrument and Equipment Suppliers, 2007
• CHAPTER SIX: ENT AND RESPIRATORY DEVICES
• Table 6-1: U.S. and Europe Procedure Volumes for ENT/Respiratory*
• Figure 6-1: U.S. and Europe Procedure Volumes for ENT and Respiratory*
• Table 6-2: MIS: ENT and Respiratory Market Analysis, 2005-2007
• Table 6-3: MIS: ENT and Respiratory Market Analysis: 2008-2012
• Figure 6-2: MIS: ENT and Respiratory Market Analysis: 2005-2012
• Table 6-4: MIS: ENT and Respiratory Market Analysis by Region/Country, 2007
• Figure 6-3: MIS: ENT and Respiratory Market Analysis by Region/Country, 2007
• Table 6-5: Leading MIS ENT and Respiratory Instrument and Equipment Suppliers, 2007
• CHAPTER SEVEN: CARDIOVASCULAR DEVICES
• Table 7-1: U.S. and Europe Procedure Volumes for Cardiovascular Surgery*
• Figure 7-1: U.S. and Europe Procedure Volumes for Cardiovascular Surgery*
• Table 7-2: MIS: Cardiovascular Market Analysis, 2005-2007
• Table 7-3: MIS: Cardiovascular Market Analysis: 2008-2012
• Figure 7-2: MIS: Cardiovascular Market Analysis: 2005-2012
• Table 7-4: MIS: Cardiovascular Market Analysis by Region/Country, 2007
• Figure 7-3: MIS: Cardiovascular Market Analysis by Region/Country, 2007
• Table 7-5: Leading MIS Cardiovascular Instrument and Equipment Suppliers, 2007
• CHAPTER EIGHT: GASTROINTESTINAL SYSTEM DEVICES
• Table 8-1: U.S. and Europe Procedure Volumes for Gastrointestinal System*
• Figure 8-1: U.S. and Europe Procedure Volumes for Gastrointestinal System*
• Table 8-2: MIS: Gastrointestinal System Market Analysis, 2005-2007
• Table 8-3: MIS: Gastrointestinal System Market Analysis: 2008-2012
• Figure 8-2: MIS: Gastrointestinal System Market Analysis: 2005-2012
• Table 8-4: MIS: Gastrointestinal System Market Analysis by Region/Country, 2007
• Figure 8-3: MIS: Gastrointestinal System Market Analysis by Region/Country, 2007
• Table 8-5: Leading MIS Gastrointestinal System Instrument and Equipment Suppliers, 2007
• CHAPTER NINE: UROLOGICAL AND GYNECOLOGICAL DEVICES
• Table 9-1: U.S. and Europe Procedure Volumes for Urological and Gynecological*
• Figure 9-1: U.S. and Europe Procedure Volumes for Urological and Gynecological*
• Table 9-2: MIS: Urological and Gynecological Market Analysis, 2005-2007
• Table 9-3: MIS: Urological and Gynecological Market Analysis: 2008-2012
• Figure 9-2: MIS: Urological and Gynecological Market Analysis: 2005-2012
• Table 9-4: MIS: Urological and Gynecological Market Analysis by Region/Country, 2007
• Figure 9-3: MIS: Urological and Gynecological Market Analysis by Region/Country, 2007
• Table 9-5: Leading MIS Urological and Gynecological Instrument and Equipment Suppliers, 2007
• CHAPTER TEN: TOTAL MARKET SIZE AND FORECAST DEVICES
• Table 10-1: MIS: Total Market Analysis, 2005-2007
• Table 10-2: MIS: Total Market Analysis: 2008-2012
• Figure 10-1: MIS: Total Market Analysis: 2005-2012
• Table 10-3: Minimally Invasive Surgery Market Analysis by Application, 2005-2007
• Table 10-4: Minimally Invasive Surgery Market Analysis by Application, 2008-2012
• Figure 10-2: Minimally Invasive Surgery Market Analysis by Application, 2005-2012
• Figure 10-3: Minimally Invasive Surgery Market Share by Application, 2007
• Figure 10-4: Minimally Invasive Surgery Market Share by Application, 2012
• Table 10-5: MIS: U.S. Market Analysis by Segment, 2007
• Figure 10-5: MIS: U.S. Market Analysis by Segment, 2007
• Table 10-6: MIS: Europe Market Analysis by Segment, 2007
• Figure 10-6: MIS: Europe Market Analysis by Segment, 2007
• Table 10-7: MIS: Rest of World Market Analysis by Segment, 2007
• Figure 10-7: MIS: Rest of World Market Analysis by Segment, 2007
• Table 10-8: Total Minimally Invasive Surgery Market Estimated Revenues and Market Share of Leading Suppliers 2007
• Figure 10-8: Total Minimally Invasive Surgery Estimated Market Share by Leading Suppliers 2007
• CHAPTER ELEVEN: CORPORATE PROFILES DEVICES
• Figure 11-1: Aesculap’s Net Revenues for 2006 and 2007
• Figure 11-2: Boston Scientific’s Net Revenues and R&D Expenses for 2006 and 2007
• Figure 11-3: Conmed’s Net Revenues and R&D Expenses for 2006 and 2007
• Figure 11-4: Covidien’s Net Revenues and R&D Expenses for 2006 and 2007
• Figure 11-5: Given Imaging’s Net Revenues and R&D Expenses for 2006 and 2007
• Figure 11-6: Johnson & Johnson and Ethicon Endo-Surgery’s Net Revenues and Johnson & Johnson’s R&D Expenses for 2006 and 2007
• Figure 11-7: Medtronic’s Net Revenues and R&D Expenses for 2006 and 2007
• Figure 11-8: Olympus’ Net Revenues and R&D Expenses for 2006 and 2007
• Figure 11-9: Smith & Nephew’s Net Revenues and R&D Expenses for 2006 and 2007
• Figure 11-10: Stryker’s Net Revenues and R&D Expenses for 2006 and 2007
• ASIAN DEVICE MARKETS
• Chapter One: Executive Summary
  • 1.1 Healthcare Industry
  • 1.2 Healthcare In Asia
  • 1.3 Definition And Scope
  • 1.4 Medical Devices
  • 1.5 Market Overview
    • 1.5.3 Australia
    • 1.5.2 China
    • 1.5.5 India
    • 1.5.1 Japan
    • 1.5.4 South Korea
  • 1.6 Demand Side Analysis
    • 1.6.3 Australia
    • 1.6.2 China
    • 1.6.5 India2
    • 1.6.1 Japan
    • 1.6.4 South Korea
  • 1.7 Key Regulations And Certifications
    • 1.7.3 Australia
    • 1.7.2 China
    • 1.7.5 India
    • 1.7.1 Japan
    • 1.7.4 South Korea
  • 1.8 Conclusions

Chapter Two: Introduction

• 2.1 Healthcare Industry
  • 2.1.1 Worldwide Healthcare Market
• 2.2 Healthcare in Asia
  • 2.2.1 Asia – Healthcare Statistics
  • 2.2.1.1 Healthcare Spending as a Percentage of GDP
  • 2.2.1.2 Per Capita Healthcare Spending
  • 2.2.2 Trends in Asian Healthcare Markets
• 2.3 Definition and Scope
  • 2.3.1 Definition
  • 2.3.2 Geographical Scope of the Study

Chapter three: Classification of Medical Devices

• 3.1 Definition
• 3.2 Classification of Medical Devices
• 3.3 Categorization of Medical Devices

Chapter four: Market Data & Analysis

• 4.1 Australia
  • 4.1.1 Market Size
  • 4.1.2 Market Size Projections
  • 4.1.3 Industry Structure
  • 4.1.4 Trends
  • 4.1.4.1 Import-Export Trends
  • 4.1.4.2 Australian Medical Devices – Worldwide Acceptance
  • 4.1.4.3 Medical Devices vs Pharmaceutical Products – Development Cycle
  • 4.1.5 Factors Affecting the Market
  • 4.1.5.1 Growth Drivers
  • 4.1.5.2 Growth Inhibitors
• 4.2 China
  • 4.2.1 Market Size
  • Taiwan Market
  • 4.2.2 Market Size Projections
  • 4.2.3 Trends
  • 4.2.4 Factors Affecting the Market
  • 4.2.4.1 Growth Drivers
  • 4.2.4.2 Growth Inhibitors
• 4.3 India
  • 4.3.1 Market Size
  • 4.3.2 Market Size Projections
  • 4.3.3 Trends
  • 4.3.3.1 Import-Export Trends
  • 4.3.3.2 Medical Tourism
  • 4.3.4 Factors Affecting the Market
  • 4.3.4.1 Growth Drivers
• 4.4 Japan
  • 4.4.1 Market Size
  • 4.4.2 Market Size Projections
  • 4.4.3 Industry Structure
  • 4.4.3.1 Business through General Dealers
  • 4.4.3.2 Business through Specialist Dealers
  • 4.4.3.3 Direct Sales
  • 4.4.4 Trends
  • 4.4.4.1 Import-Export Trends
  • 4.4.4.2 Eldercare Market
  • 4.4.5 Factors Affecting the Market
  • 4.4.5.1 Growth Drivers
  • 4.4.5.2 Growth Inhibitors
• 4.5 South Korea
  • 4.5.1 Market Size
  • 4.5.2 Market Size Projections
  • 4.5.3 Trends
  • 4.5.3.1 Import-Export Trends
  • 4.5.4 Factors Affecting the Market
  • 4.5.4.1 Growth Drivers
  • 4.5.4.2 Growth Inhibitors

Chapter Five: Demand Side Analysis

• 5.1 Australia
  • 5.1.1 Demand Side Statistics
  • 5.1.1.1 Increase in the Number of Hospitals and Related Expenditure
  • 5.1.1.2 Statistics Related to Medical Procedures
  • 5.1.2 Demographics
  • 5.1.2.1 Increase in the Number of People Aged 65 Years and Above
• 5.2 China
  • 5.2.1 Potential Market for Replacement Sales
  • 5.2.2 Higher Demand for Medical Devices from ‘Retirement Homes’
  • 5.2.3 Demand for High-Quality Medical Devices and More Efficient Healthcare Services
  • 5.2.4 Increased Acceptance of Diagnostic Devices in Taiwan
• 5.3 India
  • 5.3.1 Public Sector vs Private Sector
  • 5.3.2 Healthcare Infrastructure
  • 5.3.2.1 Government Healthcare Infrastructure
  • 5.3.2.2 Private Healthcare Infrastructure
  • 5.3.3 Demographics
  • 5.3.3.1 Increase in the Number of People Aged 65 Years and Above
• 5.4 Japan
  • 5.4.1 Demographics
  • 5.4.1.1 Increase in the Number of People Aged 65 Years and Above
  • 5.4.2 Medical Devices Preferences
• 5.5 South Korea
  • 5.5.1 Modernization of Hospitals
  • 5.5.2 Increasing Demand for Homecare Medical Devices

Chapter Six: Key Regulations and Certifications

• 6.1 Global Regulatory Bodies
  • 6.1.1 Global Harmonization Task Force (GHTF)
  • 6.1.2 US Food and Drug Administration (US FDA)
• 6.2 Australia
  • 6.2.1 Regulatory Bodies and Committees
  • 6.2.1.1 Therapeutic Goods Administration (TGA)
  • 6.2.1.2 The Australian Register of Therapeutic Goods (ARTG)
• 6.3 China
  • 6.3.1 Key Regulations
  • 6.3.2 Regulations and Registrations in Taiwan
  • 6.3.3 Recent Regulatory Changes
  • 6.3.3.1 Medical Devices Testing
  • 6.3.3.2 New Pricing Policy for Medical Devices
  • 6.3.3.3 New Regulation – Medical Devices Quality System Management
  • 6.3.3.4 Registration
  • 6.3.3.5 Supervising Medical Devices Manufacturers
• 6.4 India
  • 6.4.1 Regulatory Bodies and Committees
  • 6.4.1.1 Indian Medical Devices Regulatory Authority
  • 6.4.1.2 Central Drug Standard Control Organization (CDSCO)
• 6.5 Japan
  • 6.5.1 Regulations
  • 6.5.1.1 Revision of Medical Devices Approval Applications Classifications
  • 6.5.2 Certifications
  • 6.5.2.1 MHLW Ministerial Ordinance No. 169, 2004
  • 6.5.2.2 MHLW Ministerial Ordinance No. 2, 1961, revised by MHLW Ministerial Ordinance No. 73, 2005
  • 6.5.2.3 MHLW Ministerial Ordinance No. 136, 2004
• 6.6 South Korea
  • 6.6.1 Key Regulations
  • 6.6.2 Registrations for Medical Devices Approval
  • 6.6.2.1 Classification of Medical Devices
  • 6.6.2.2 Manufacturing/Importing Approval/Announcement Application
  • 6.6.2.3 Examination of Technical Documents
  • 6.6.2.4 Testing
  • 6.6.2.5 Medical Devices Manufacture/Import and Quality Control Rules

Chapter Seven: Conclusions

• 7.1 First Conclusion
• 7.2 Second Conclusion
• 7.3 Third Conclusion
• 7.4 Fourth Conclusion
• 7.5 Fifth Conclusion
• 7.6 Sixth Conclusion
• 7.7 Seventh Conclusion

Chapter Eight: Company Profiles

• 8.1 3M Company
  • 8.1.1 Key Facts
  • 8.1.2 Company Overview
  • 8.1.3 Geographical Presence and Subsidiaries
  • 8.1.4 Product Portfolio
  • 8.1.5 Key Executives
  • 8.1.6 Performance Review
  • 8.1.6.1 Revenue Performance
  • 8.1.6.2 Performance of Business Segments
  • 8.1.6.3 Performance of Geographic Segments
  • 8.1.6.4 Performance of the Healthcare Segment
  • 8.1.7 Company Strategy
• 8.2 B Braun Melsungen Ag (B. Braun)
  • 8.2.1 Key Facts
  • 8.2.2 Company Overview
  • 8.2.3 Product Portfolio
  • 8.2.4 Key Executives
  • 8.2.5 Key Competitors
  • 8.2.6 Performance Review
  • 8.2.6.1 Revenue Performance
  • 8.2.6.2 Performance of Business Segments
  • 8.2.6.3 Performance of Geographic Segments
• 8.3 Beijing Wandong Medical Equipment Co., Ltd
  • 8.3.1 Key Facts
  • 8.3.2 Company Overview
  • 8.3.3 Geographical Presence and Business Lines
  • 8.3.4 Product Portfolio
  • 8.3.5 Key Executives
  • 8.3.6 Key Competitors
  • 8.3.7 Performance Review
  • 8.3.7.1 Revenue Performance
  • 8.3.7.2 Performance of Business Segments
  • 8.3.7.3 Performance of Geographic Segments
  • 8.3.8 Company Strategy
• 8.4 Cochlear Limited
  • 8.4.1 Key Facts
  • 8.4.2 Company Overview
  • 8.4.3 Geographical Presence and Subsidiaries
  • 8.4.4 Product Portfolio
  • 8.4.4.1 Nucleus Freedom Cochlear Implant System
  • 8.4.4.2 Baha System
  • 8.4.5 Key Executives
  • 8.4.6 Performance Review
  • 8.4.6.1 Revenue Performance
  • 8.4.7 Company Strategy
• 8.5 GE Healthcare Company
  • 8.5.1 Key Facts
  • 8.5.2 Company Overview
  • 8.5.3 Geographical Presence and Business Lines
  • 8.5.4 Product Portfolio
  • 8.5.5 Staff Organization
  • 8.5.7 Key Competitors
  • 8.5.8 Performance Review
  • 8.5.8.1 Revenue Performance
  • 8.5.8.2 Performance of Business Segments
  • 8.5.9 Company Strategy
• 8.6 Hitachi Medical Corporation
  • 8.6.1 Key Facts
  • 8.6.2 Company Overview
  • 8.6.3 Geographical Presence and Business Lines
  • 8.6.4 Product Portfolio
  • 8.6.5 Organization of Business
  • 8.6.6 Key Executives
  • 8.6.7 Key Competitors
  • 8.6.8 Performance Review
  • 8.6.8.1 Revenue Performance
  • 8.6.8.2 Performance of Business Segments
  • 8.6.8.3 Performance of Geographic Segments
• 8.7 Johnson & Johnson Co., Ltd
  • 8.7.1 Key Facts
  • 8.7.2 Company Overview
  • 8.7.3 Geographical Presence and Business Lines
  • 8.7.4 Product Portfolio
  • 8.7.5 Staff Organization
  • 8.7.6 Key Executives
  • 8.7.7 Key Competitors
  • 8.7.8 Performance Review
  • 8.7.8.1 Revenue Performance
  • 8.7.8.2 Performance of Business Segments
  • 8.7.8.3 Performance of Geographic Segments
  • 8.7.9 Company Strategy
• 8.8 Medison Co., Ltd
  • 8.8.1 Key Facts
  • 8.8.2 Company Overview
  • 8.8.3 Geographical Presence and Business Lines
  • 8.8.4 Product Portfolio
  • 8.8.5 Staff Organization
  • 8.8.5.1 Marketing Services
  • 8.8.5.2 Research and Development Services
  • 8.8.5.3 Production Services
  • 8.8.5.4 Administration Services
  • 8.8.6 Key Executives
  • 8.8.7 Key Competitors
  • 8.8.8 Performance Review
  • 8.8.8.1 Revenue Performance
  • 8.8.8.2 Performance of Business Segments
  • 8.8.9 Company Strategy
• 8.9 Philips Medical Systems Technologies Ltd
  • 8.9.1 Key Facts
  • 8.9.2 Company Overview
  • 8.9.3 Geographic Presence
  • 8.9.4 Product Portfolio
  • 8.9.6 Key Competitors
  • 8.9.7 Performance Review
  • 8.9.7.1 Revenue Performance
  • 8.9.7.2 Performance of Geographic Segments
  • 8.9.8 Company Strategy
• 8.10 ResMed, Inc.
  • 8.10.1 Key Facts
  • 8.10.2 Company Overview
  • 8.10.4 Product Portfolio
  • 8.10.5 Key Executives
  • 8.10.6 Performance Review
  • 8.10.6.1 Revenue Performance
  • 8.10.6.2 Performance of Geographic Segments
  • 8.10.7 Company Strategy
  • 8.10.7.1 Core Growth Strategies
  • 8.10.7.2 Strategic Acquisitions
  • 8.10.7.3 Global Sales and Marketing
  • 8.1.9.4 Collaboration with Associations
• 8.11 Siemens Medical Solutions
  • 8.11.1 Key Facts
  • 8.11.2 Company Overview
  • 8.11.3 Geographical Presence and Business Lines
  • 8.11.4 Product Portfolio
  • 8.11.5 Key Executives
  • 8.11.6 Key Competitors
  • 8.11.7 Performance Review
  • 8.11.7.1 Revenue Performance
• 8.12 Terumo Corporation
  • 8.12.1 Key Facts
  • 8.12.2 Company Overview
  • 8.12.3 Geographical Presence and Business Lines
  • 8.12.4 Product Portfolio
  • 8.12.5 Key Executives
  • 8.12.6 Key Competitors
  • 8.12.7 Performance Review
  • 8.12.7.1 Revenue Performance
  • 8.12.7.2 Performance of Business Segments
  • 8.12.7.3 Performance of Geographic Segments
  • 8.12.8 Company Strategy
• 8.13 Toshiba Medical Systems Corporation
  • 8.13.1 Key Facts
  • 8.13.2 Company Overview
  • 8.13.3 Geographical Presence and Business Lines
  • 8.13.4 Product Portfolio
  • 8.13.5 Organization of Business
  • 8.13.6 Key Executives
  • 8.13.7 Key Competitors
  • 8.13.8 Performance Review
  • 8.13.8.1 Revenue Performance
  • 8.13.8.2 Performance of Business Segments
  • 8.13.8.3 Performance of Geographic Segments

ASIAN DEVICE MARKET LIST OF EXHIBITS

Chapter One: Executive Summary

• Figure 1-1: Expenditure on Healthcare as a Percentage of GDP – Asia (2005-2006)
• Figure 1-2: Medical Device Categories
• Figure 1-3: Asian Medical Device Markets (Australia, China, India, Japan,
• South Korea), 2006-2010

CHAPTER two: Introduction

• Figure 2-1: Value Chain of the Healthcare Industry
• Table 2-1: World Population Predictions 2005 and 2050
• Figure 2-2: Healthcare Spending as a Percentage of GDP – Asia (2005-2010)
• Figure 2-3: Per Capita Healthcare Spending – Asia (2005-2010)
• Figure 2-4: Total Healthcare Expenditure Break-up for Asia Pacific (2005)
• Figure 2-5: Expenditure on Healthcare as a Percentage of GDP – Asia (2005-2006)
• Figure 2-6: Per Capita Healthcare Spending – Asia (2005-2006)

Chapter three: Classification of Medical Devices

• Figure 3-1: Medical Device Classification
• Figure 3-2: Medical Device Categories
• Figure 3-3: Classification of Surgical Equipment

Chapter four: Market Data & Analysis

• Table 4-1: Asian Medical Device Market, 5 Key Countries (Australia, China, India, Japan, South Korea) 2007-2010
• Figure 4-1: Australian Medical Device market Size (2003-2005)
• Figure 4-2: Australian Medical Device Market Size – Projection (2007-2010)
• Figure 4-3: Australian Medical Device market – Segmentation
• (Diagnostic/Imaging Equipment, Ophthalmic Equipment, Others), 2006
• Figure 4-4: Australian Medical Device Industry Structure
• Figure 4-5: Australia – Domestic Production (2004)
• Figure 4-6: Australia – Domestic Consumption (2004)
• Figure 4-7: Medical Devices vs Pharmaceutical Products – Development Cycle
• Figure 4-8: Aging Population – Australia (Age Group 65 Years and above)
• Figure 4-9: Public Sector vs Private Sector Purchase of Medical Devices – Australia (2005)
• Figure 4-10: Chinese Medical Device market Size (2000-2006)
• Figure 4-11: Production Value of Medical Devices in Taiwan (2002-2006)
• Figure 4-12: Chinese Medical Device market Size – Projection (2005-2010)
• Figure 4-13: Chinese Medical Device market – Segmentation (IV Diagnostics Equipment, Disposable Equipment, Ophthalmic Equipment, Others) , 2006 (in USD million) Figure 4-14: Indian Medical Device market Size (1993, 2005-2006)
• Figure 4-15: Indian Medical Device market Size – Projection (2007-2010)
• Figure 4-16: Indian Medical Device market – Segmentation (Diagnostic Equipment, Imaging Equipment, Others)
• Figure 4-17: India – Domestic Consumption (2004)
• Figure 4-18: Medical Tourism Industry in India (2006-2012)
• Figure 4-19: Japanese Medical Device market Size (2000-2006)
• Figure 4-20: Japanese Medical Device market Size – Projection (2006-2010)
• Figure 4-21: Japanese Medical Device market – Segmentation (IV Diagnostic
• Equipment, Disposable Equipment, Ophthalmic Equipment, Others), 2006
• Figure 4-22: Distribution Patterns for Medical Devices in Japan
• Figure 4-23: Import and Export of Japanese Medical Devices as a Percent of Market Output (1997-2007)
• Table 4-2: Population Needing Home Treatment – Forecast (1993-2025)
• Table 4-3: Average Age of Japan’s Population (1990-2005)
• Figure 4-24: South Korean Medical Device market Size (2000-2006)
• Figure 4-25: Medical Devices Manufacturing Market (2000-2006)
• Figure 4-26: Medical Devices Manufacturing Companies’ Market Share (2004)
• Figure 4-27: South Korea Medical Device market Size – Projection (2007-2010)
• Figure 4-28: South Korean Medical Device market – Segmentation
• (Disposable and Non-Disposable Equipment, 2006
• Figure 4-29: South Korea Medical Devices Imports (2000-2010)

Chapter Five: Demand Side Analysis

• Figure 5-1: Public Sector vs Private Sector – Purchase of Medical Devices (2006)
• Table 5-1: Number of Hospitals (2000-2001 to 2004-2005)
• Figure 5-2: Number of Public Hospitals vs Private Hospitals – Australia (2005)
• Table 5-2: Total Recurrent Expenditure from 2000-2001 to 2004-2005
• Table 5-3: Statistics for Public Hospitals – by Procedure (2004-2005)
• Table 5-4: Procedure Statistics for Private Hospitals – by Procedure (2004-2005)
• Figure 5-3: Aging Population – Australia (Age Group of 65 Years and Above)
• Figure 5-4: Supply-Demand Gap in China’s Medical Device market (2003-2008)
• Figure 5-5: Healthcare Industry – Public Sector vs Private Sector (2006)
• Table 5-5: Healthcare Infrastructure in India (2004)
• Table 5-6: Size of Private Hospitals – Healthcare Units (2004)
• Table 5-7: Demographics Forecast (2010-2050).
• Table 5-8: Aging Demographics Forecast (2000-2050)

Chapter Six: Key Regulations and Certifications

• Figure 6-1: Australian Medical Devices Legislation – Features
• Figure 6-2: Australian Medical Devices – Route to Market
• Figure 6-3: Drug and Cosmetics Act – Implementation Framework – Central and State Drug Administrations (CDA)
• Figure 6-4: Structure of Central Drug Standard Control Organization
• Table 6-1: Approval, Licensing, and Notification System – Pharmaceutical Affairs Law

Chapter Seven: Conclusions

• Figure 7-1: Asian Medical Device Markets – Market Attractiveness Chart

Chapter Eight: Company Profiles

• Table 8-1: Corporate Details of 3M
• Table 8-2: Geographical Presence and Subsidiaries of 3M
• Table 8-3: Key Executives of 3M
• Figure 8-1: 3M Revenue Performance (2001-2006)
• Figure 8-2: 3M Revenues (by Business Segment) (2006)
• Figure 8-3: 3M Revenues (by Geography) (2006)
• Figure 8-4: 3M Revenues (Healthcare Segment) (2004-2006)
• Table 8-4: Corporate Details of B. Braun
• Table 8-5: Product Portfolio of B. Braun
• Table 8-6: Key Executives of B. Braun
• Figure 8-5: B. Braun Revenue Performance (2004-2005)
• Figure 8-6: B. Braun Revenues (by Business Segment) (2005)
• Figure 8-7: B. Braun Revenues (by Geography) (2005)
• Table 8-7: Corporate Details of Beijing Wandong Medical Equipment
• Table 8-8: Major Branches and Business Lines of Wandong Medical
• Table 8-9: Key Executives of Wandong Medical
• Figure 8-8: Wandong Medical Revenue Performance (2001-2005)
• Figure 8-9: Wandong Medical Revenues (by Business Segment) (2005)
• Figure 8-10: Wandong Medical Revenues (by Geography) (2005)
• Table 8-10: Corporate Details of Cochlear Limited
• Table 8-11: Geographical Presence and Subsidiaries of Cochlear
• Table 8-12: Key Executives of Cochlear
• Figure 8-11: Cochlear Revenue Performance (2001-2006)
• Figure 8-12: Cochlear Revenues (by Geography) (2006)
• Figure 8-13: Cochlear Revenue Performance (by Geography) (2004-2006)
• Table 8-13: Corporate Details of GE Healthcare
• Table 8-14: Major (Asia Pacific) Operating Locations and Business Lines of GE Healthcare
• Table 8-15: Key Executives of GE Healthcare
• Figure 8-14: GE Healthcare Revenue Performance (2002-2006)
• Figure 8-15: GE Revenues (by Business Segment) (2006)
• Figure 8-16: GE Income (by Business Segment) (2006)
• Table 8-16: Corporate Details of Hitachi Medical Corporation
• Table 8-17: Geographical Presence and Business Lines of Hitachi Medical Corporation
• Table 8-18: Key Executives of Hitachi Medical Corporation
• Figure 8-17: Hitachi Medical Corporation Revenue Performance (2004-2006)
• Figure 8-18: Hitachi Medical Revenue Performance (by Business Segment) (2006)
• Figure 8-19: Hitachi Medical Revenue Performance (by Geography) (20006)
• Table 8-19: Corporate Details of Johnson & Johnson
• Table 8-20: Major Locations and Business Lines of Johnson & Johnson in Asia Pacific
• Table 8-21: Key Executives of Johnson & Johnson
• Figure 8-20: Johnson & Johnson Revenue Performance (2002-2006)
• Figure 8-21: Johnson & Johnson Revenues (by Business Segment) (2006)
• Figure 8-22: Johnson & Johnson Revenues (by Geography) (2006)
• Figure 8-23: Medical Devices and Diagnostics Segment Revenues (by Geography) (2006)
• Table 8-22: Corporate Details of Medison
• Table 8-23: Geographical Presence and Business Lines of Medison
• Table 8-24: Key Executives of Medison
• Figure 8-24: Medison Revenue Performance (2002-2005)
• Figure 8-25: Medison Revenues (by Geography) (2005)
• Table 8-25: Corporate Details of Philips Medical Systems Technologies Ltd
• Table 8-26: Presence of Philips Medical Systems in Asia Pacific
• Table 8-27: Key Executives of Philips Medical Systems
• Figure 8-26: Philips Medical Systems Revenue Performance (2002-2006)
• Figure 8-27: Philips Medical Systems Revenues (by Geography) (2002-2006)
• Table 8-28: Corporate Details of ResMed, Inc.
• Table 8-29: Geographical Presence of ResMed
• Table 8-30: Product Portfolio of ResMed
• Table 8-31: Key Executives of ResMed
• Figure 8-28: ResMed Revenue Performance (2002-2006)
• Figure 8-29: ResMed Revenues (by Geography) (2006)
• Table 8-32: Acquisitions of ResMed (1996-2005)
• Table 8-33: Corporate Details of Siemens Medical Solutions
• Table 8-34: Geographical Presence and Business Lines of Siemens Medical Solutions
• Table 8-35: Key Executives of Siemens Medical Solutions
• Figure 8-30: Siemens Medical Solutions Revenue Performance (2002-2006)
• Table 8-36: Corporate Details of Terumo Corporation
• Table 8-37: Geographical Presence and Business Lines of Terumo Corporation
• Table 8-38: Key Executives of Terumo
• Figure 8-31: Terumo Corporation Revenue Performance (2004-2006)
• Figure 8-32: Terumo Corporation Revenues (by Business Segment) (2006)
• Figure 8-33: Terumo Corporation Revenues (by Geography) (2006)
• Table 8-39: Corporate Details of Toshiba Medical Systems Corporation
• Table 8-40: Geographical Presence and Business Lines of Toshiba Medical Systems Corporation
• Figure 8-34: Business Divisions of Toshiba Corporation
• Table 8-41: Key Executives of Toshiba Corporation
• Figure 8-35: Toshiba Revenue Performance (by Business Segment) (2005)
• Figure 8-36: Toshiba Revenue Performance (by Geography) (2005)

TABLE OF CONTENTS

CONTRACT MANUFACTURING IN MEDICAL DEVICE MARKETS

Chapter One: Executive Summary

• Finished Clinical Products and Systems
• Scope & Methodology

Chapter TWO: Finished Clinical Products and

• Systems Sectors
• Description of Sectors
• Medical Device Implantable Products
• Medical Single Use Products
• Surgical Instruments Reusable and Single Use
• Patient Monitoring Products and Systems
• Diagnostic Laboratory Equipment and Scientific Instruments
• Imaging Products and Systems
• Networking IT technology and Telemetry Products

Chapter Three: Therapeutic Area Segments

Chapter FouR: Overall Global Medical Device Market

• Worldwide Company Revenues
• Market Share of Device Companies

Chapter five: Issues and Trends in the Global O.E.M Market and CMO Market

• Outsourcing Challenges
• The Business Climate
• Reimbursement Concerns
• Other Challenges
• Process Equipment
• Outsourcing Benefits
• Offshoring and Partering
• Changing Relationships
• MPO Climate
• A Closer Look at Outsourcing Trends
• Getting Terms in Writing
• Impact of Group Purchasing Power (GPO’s) and e-Commerce
• e-Commerce
• Problems
• Product Suitability
• Global Healthcare Exchange (GHX)
• Supply Chain Solutions
• Pharma Solutions
• Solutions that Benefit the Entire Healthcare Supply Chain
• Exclusive Regional Dealers
• Drivers / Trends in Medical Device Distribution
• Acquisitions
• Growing Attractiveness of Alternative Care Distribution
• Distribution Approaches and Commercialization Strategy
• New market dynamics – Combination Medical Products
• Innovation to Commodity
• The Medical Device Market Model
• The Outsourcing Picture
• Outsourcing Challenges
• The Business Climate
• Reimbursement Concerns
• Other Challenges
• Developing an “X Factor” Differentiates the OEM’s or CMO’s.
• Outsourcing Benefits
• Future Potential
• Expanding Responsibilities
• Future Development
• Poised For Growth
• Offshoring and ParteringChanging Relationships
• Medical Product Outsourcing
• A Closer Look at Outsourcing Trends
• Putting It All in Writing
• Global Healthcare Exchange (GHX)
• Supply Chain Solutions
• Market Intelligence
• Pharma Solutions
• Acquisitions
• Growing Attractiveness of Alternative Care Distribution
• Distribution Approaches and Commercialization Strategy

Chapter siX: Market Analysis & Data

• Contract Manufacturing Markets
• O.E.M ‘s and Risk Adverse Medical Device Segments
• United States Revenues
• Group Segments
• Europe Revenues
• European Market and Continuous Technological Innovation
• Group Segments
• Asia Revenues
• I.B.M – Case Study For Establishing Manufacturing in China
• Group Segments
• Rest of the World Revenues
• Group Segments
• Global Revenues
• Global Market Overview

Chapter Seven: Top O.E.M. Companies

• Agile, Inc. (Oracle)
• Avail Medical Products Corporation
• Merit Medical , Inc.
• Smiths Group Plc
• Symmetry Medical Inc
• W.L. Gore & Associates Inc
• Cardinal Health Inc
• C.R. Bard Inc
• B.Braun OEM Division
• Synovis Interventional Solutions Inc

Appendix: Other Key OEM companies

table of exhibits

• Chapter OnE: Executive Summary
• Exhibit 1-1: OEM Contract Manufacturing Market in Finished Clinical Products and Systems: 2006, 2008, 2011 (millions)
• Exhibit 1-2: OEM Contract Manufacturing Market in Finished Clinical Products and Systems by Sector (Medical Device Implantable Products, Medical Single Use Products, Surgical Instruments,Reusable and Single Use, Patient Monitoring Products and Systems, Diagnostic Laboratory Equipment and Scientific
• Instruments, Imaging Products and Systems, Networking, IT technology
• and Telemetry Products) Exhibit 1-3: Key European Medical Device Market Segments
• Exhibit 1-4: Medical Devices Product Flow Chart Process
• Exhibit 1-5: Examples of Combination Products

Chapter Four: Overall Global Medical Device Market

• Exhibit 4-1: The Worldwide Non-Commodity Medical Device Market by Sector (IVD, Imaging, Orthopedics, Cardiovascular, General Surgery, Ophthalmology, Neurology, Urology) …………. 25
• Exhbit 4-2: Global Market Share, Medical Device Companies
• Exhibit 4-3: Top 20 Companies and Reported 2005 Revenues

Chapter five: Issues and Trends in the Global O.E.M Market and CMO Market

• Exhibit 5-1: Examples of Combination Products

Chapter siX: Market Analysis & Data

• Exhibit 6-1: OEM Contract Manufacturing Market in Finished Clinical
• Products and Systems: 2006, 2008, 2011 (millions)
• Exhibit 6-2: OEM Contract Manufacturing Market by Sector
• Exhibit: 6-3: United States Non-Commodity OEM Revenues 2006 – 2011
• Exhibit 6-4: United States Commodity OEM Revenues 2006 – 2011
• Exhibit 6-5: United States Estimated Revenues Cardiovascular 2006 – 2011 by Sector (Medical Device Implantable Products, Medical Single Use Products, Surgical Instruments,Reusable and Single Use, Patient Monitoring Products and Systems, Diagnostic Laboratory Equipment and Scientific Instruments, Imaging Products and Systems, Networking, IT technology and Telemetry Products)
• Exhibit 6-6: United States Estimated Revenues General Surgery 2006 – 2011 by Sector
• Exhibit 6-7: United States Estimated Revenues Imaging 2006 – 2011 by Sector
• Exhibit 6-8: United States Estimated Revenues I.V Diagnostics 2006 – 2011 by Sector
• Exhibit 6-9: United States Estimated Revenues Opthalmology 2006 – 2011 by Sector
• Exhibit 6-10: United States Estimated Revenues Orthopedics 2006 – 2011 by Sector
• Exhibit 6-11: United States Estimated Revenues Respiratory 2006 – 2011 by Sector
• Exhibit 6-12: United States Estimated Revenues Neurology 2006 – 2011 by Sector
• Exhibit 6-13: United States Estimated Revenues Urology 2006 – 2011 by Sector
• Exhibit 6-14: Europe Non Commodity OEM Revenues 2006 – 2011
• Exhibit:6-15: Europe Commodity OEM Revenues 2006 – 2011
• Exhibit 6-16: Europe Estimated Revenues Cardiovascular 2006 – 2011 by Sector (Medical Device Implantable Products, Medical Single Use Products, Surgical Instruments,Reusable and Single Use, Patient Monitoring Products and Systems, Diagnostic Laboratory Equipment and Scientific Instruments, Imaging Products and Systems, Networking, IT technology and Telemetry Products)
• Exhibit 6-17: Europe Estimated Revenues General Surgery 2006 – 2011 by Sector
• Exhibit 6-18: Europe Estimated Revenues Imaging 2006 – 2011 by Sector
• Exhibit 6-19: Europe Estimated Revenues I.V Diagnostics 2006 – 2011 by Sector
• Exhibit 6-20: Europe Estimated Revenues Opthalmology 2006 – 2011 by Sector
• Exhibit 6-21: Europe Estimated Revenues Orthopedics 2006 – 2011 by Sector
• Exhibit 6-22: Europe Estimated Revenues Respiratory 2006 – 2011 by Sector
• Exhibit 6-23: Europe Estimated Revenues Neurology 2006 – 2011 by Sector
• Exhibit 6-24: Europe Estimated Revenues Urology 2006 – 2011 by Sector
• Exhibit: 6-25: Asia Non-Commodity OEM Revenues 2006 – 2011 by Sector
• Exhibit: 6-26: Asia Commodity OEM Revenues 2006 – 2011 by Sector
• Exhibit 6-27: Asia Estimated Revenues Cardiovascular 2006 – 2011 by Sector (Medical Device Implantable Products, Medical Single Use Products, Surgical Instruments,Reusable and Single Use, Patient Monitoring Products and Systems, Diagnostic Laboratory Equipment and Scientific Instruments, Imaging Products and Systems, Networking, IT technology and Telemetry Products)
• Exhibit 6-28: Asia Estimated Revenues General Surgery 2006 – 2011 by Sector
• Exhibit 6-29: Asia Estimated Revenues Imaging 2006 – 2011 by Sector
• Exhibit 6-30: Asia Estimated Revenues I.V Diagnostics 2006 – 2011 by Sector
• Exhibit 6-31: Asia Estimated Revenues Opthalmology 2006 – 2011 by Sector
• Exhibit 6-32: Asia Estimated Revenues Orthopedics 2006 – 2011 by Sector
• Exhibit 6-33: Asia Estimated Revenues Respiratory 2006 – 2011 by Sector
• Exhibit 6-34: Asia Estimated Revenues Neurology 2006 – 2011 by Sector
• Exhibit 6-35: Asia Estimated Revenues Urology 2006 – 2011 by Sector
• Exhibit: 6-35: Rest of The World Non-Commodity OEM Revenues 2006 – 2011 by Sector
• Exhibit: 5-36: Rest of The World Commodity OEM Revenues 2006 – 2011
• Exhibit 6-37: Rest of The World Estimated Revenues Cardiovascular 2006 – 2011 by Sector (Medical Device Implantable Products, Medical Single Use Products, Surgical Instruments,Reusable and Single Use, Patient Monitoring Products and Systems, Diagnostic Laboratory Equipment and Scientific Instruments, Imaging Products and Systems, Networking, IT technology and Telemetry Products)
• Exhibit 6-38: Rest of The World Estimated Revenues General Surgery 2006 – 2011 by Sector
• Exhibit 6-39: Rest of The World Estimated Revenues Imaging 2006 – 2011 by Sector
• Exhibit 6-40: Rest of The World Estimated Revenues I.V Diagnostics 2006 – 2011 by Sector
• Exhibit 6-41: Rest of The World Estimated Revenues Opthalmology 2006 – 2011 by Sector
• Exhibit 6-42: Rest of The World Estimated Revenues Orthopedics 2006 – 2011 by Sector
• Exhibit 6-43: Rest of The World Estimated Revenues Respiratory 2006 – 2011 by SectorExhibit 6-44: Rest of The World Estimated Revenues Neurology 2006 – 2011 by Sector
• Exhibit 6-44: Rest of The World Estimated Revenues Urology 2006 – 2011 by Sector
• Exhibit: 6-45: Global Non-Commodity OEM Revenues 2006 – 2011 by Sector
• Exhibit: 6-46: Global Commodity OEM Revenues 2006 – 2011 by Sector
• Exhibit 6-47: Global Estimated Revneues Cardiology 2006-2011 by Sector (Medical Device Implantable Products, Medical Single Use Products, Surgical Instruments,Reusable and Single Use, Patient Monitoring Products and Systems, Diagnostic Laboratory Equipment and Scientific Instruments, Imaging Products and Systems, Networking, IT technology and Telemetry Products)
• Exhibit 6-48: Global Estimated Revenues General Surgery 2006 – 2011 by Sector
• Exhibit 6-49: Global Estimated Revenues Imaging 2006 – 2011 by Sector
• Exhibit 6-50: Global Estimated Revenues I.V Diagnostics 2006 – 2011 by Sector
• Exhibit 6-51: Global Estimated Revenues Opthalmology 2006 – 2011 by Sector
• Exhibit 6-52: Global Estimated Revenues Orthopedics 2006 – 2011 by Sector
• Exhibit 6-53: Global Estimated Revenues Respiratory 2006 – 2011 by Sector
• Exhibit 6-53: Global Estimated Revenues Neurology 2006 – 2011 by Sector
• Exhibit 6-54: Global Estimated Revenues Urology 2006 – 2011 by Sector

CATHETER MARKETS

chapter one: Executive Summary

• 1.1 Perspective
• 1.2 Key Applications
• 1.3 Major Concerns
• 1.3.1 Infections
• 1.4. World Market Summary
• 1.5 Methodology

chapter two: Introduction

• 2.1 Definition
  • 2.1.1 Key Types
  • 2.1.1.1 Urological
  • 2.1.1.2 Cardiovascular
  • 2.1.1.3 Intravenous
  • 2.1.1.4 Specialty
  • 2.1.1.5 Stents
• 2.2 Trends
  • 2.2.1 Delivering Treatment
  • 2.2.2 Stents
  • 2.2.3 Outsourcing Skills
  • 2.2.4 Requirements for Minimally Invasive Surgery
  • 2.2.5 Alternative Materials and Processing
  • 2.2.6 Sensor-Based Catheter Systems
• 2.3 Issues
  • 2.3.1 Catheter Malfunction
  • 2.3.2 Catheter-Related Deep Vein Thrombosis
  • 2.3.3 Antimicrobial Lock Solutions

CHAPTER THREE: Issues, Trends and New Product

• Development
• 3.1 Heart Catheters
• 3.2 Antiseptic-Coated Catheters
• 3.3 Interventional Radiology
• 3.4 In Vitro Fertilization
• 3.5 MRI Catheter
• 3.6 Heart Patch
• 3.7 PFO Closure
• 3.8 Pulmonary Artery Catheterization
• 3.9 Stroke Treatment
• 3.10 Sinus Balloon Catheter Safety
• 3.11 Inappropriate Catheterization

CHAPTER FOUR: Market Analysis

• 4.1 Overview
• 4.2 Urological Catheters
  • 4.2.1 Foley
  • 4.2.2 Urethral
  • 4.3 Cardiovascular Catheters
    • 4.3.1 PTCA
    • 4.3.2 Atherectomy
    • 4.3.3 Ablation Electrophysiology
    • 4.3.4 Cardiac Angiography
    • 4.3.5 Peripheral Vascular Angiography
    • 4.4 Intravenous Catheters
      • 4.4.2 Peripheral Insertion
      • 4.4.3 Peripherally Inserted Central Catheters
      • 4.4.4 Peripheral Insertion Midline
      • 4.5 Specialty Catheters
        • 4.5.1 Wound Drainage
        • 4.5.2 Suction
        • 4.5.3 Oximetry
        • 4.5.4 Thermodilution

CHAPTER FIVE: COMPANY PROFILES

• 5.1 Abbott
• 5.2 AngioDynamics
• 5.3 Arrow International Inc.
• 5.4 Atrium Medical Corp.
• 5.5 Bactiguard AB
• 5.6 C. R. Bard Inc.
• 5.7 Becton, Dickinson and Co.
• 5.8 Biosense Webster Inc.
• 5.9 Boston Scientific
• 5.10 B. Braun Melsungen AG
• 5.11 Cardinal Health
• 5.12 Carmeda AB
• 5.13 CoAxia Inc.
• 5.14 Cook Group Inc.
• 5.15 CRI
• 5.16 CSIRO
• 5.17 Edwards Lifesciences
• 5.18 Enpath Medical Inc.
• 5.19 Flexicath Ltd.
• 5.20 FlowCardia Inc.
• 5.21 Hansen Medical
• 5.22 Iapyx Medical
• 5.23 Integra LifeSciences Holdings Corp.
• 5.24 Irvine Scientific
• 5.25 Johnson & Johnson Cordis Corp.
• 5.26 Medtronic Inc.
• 5.27 RITA Medical Systems
• 5.28 Rusch Inc.
• 5.29 Siemens Medical Solutions
• 5.30 Smiths Medical MD Inc.
• 5.31 St. Jude Medical Inc.
• 5.32 Terumo Corp.
• 5.33 Vascular Solutions Inc.
• 5.34 Ventrex Inc.
• 5.35 Welford Manufacturing
• 5.36 Zimmer Holdings Inc.
• 5.37 Spire Biomedical Inc.

Table of exhibits

chapter one: Executive Summary

• Exhibit 1: World Market for Catheters, 2007, 2009, 2012
• Exhibit 2: World Market for Catheters, 2007, 2009, 2012

chapter FOUR: MARKET ANALYSIS

• Exhibit 3: World Market for Catheters: Revenues, 2007-2012
• Exhibit 4: World Market for Catheters: Unit Sales 2007-2012
• Exhibit 5: Unit Sales: Coated vs. Uncoated Devices: 2007-2012
• Exhibit 6: Unit Sales: Coated vs. Uncoated Devices: 2007-2012
• Exhibit 7: World Market for Urological Catheters: Revenues, 2003-2012
• Exhibit 8: World Market for Urological Catheters: Unit Sales , 2003-2012
• Exhibit 9: World Market for Urological Catheters Percentage of Revenues by Region (US, Europe, Japan, ROW), 2007
• Exhibit 10: World Market for Foley Catheters: Revenues, 2003-2012
• Exhibit 11: World Market for Foley Catheters: Unit Sales, 2003-2012
• Exhibit 12: World Market for Foley Catheters Market Share by Competitor, 2007
• Exhibit 13: World Market for Urethral Catheters , 2003-2012
• Exhibit 14: World Market for Urethral Catheters , 2003-2012
• Exhibit 15: World Market for Urethral Catheters Market Share by Competitor, 2007
• Exhibit 16: Worldwide Percentage of Illness Caused by Cardiovascular Disease
• Exhibit 17: World Market for PTCA Catheters, 2003-2012, Revenues
• Exhibit 18: World Market for PTCA Catheters, 2003-2012, Unit Sales
• Exhibit 19: World Market for PTCA Catheters Market Share by Competitor, 2007
• Exhibit 20: World Market for Atherectomy Catheters , 2003-2012, Revenues
• Exhibit 21: World Market for Atherectomy Catheters , 2003-2012, Unit Sales
• Exhibit 22: World Market for Atherectomy Catheters Market Share by Competitor, 2007
• Exhibit 23: World Market for Ablation Electrophysiology Catheters, Revenues, 2003-2012
• Exhibit 24: World Market for Ablation Electrophysiology Catheters, Unit Sales, 2003-2012
• Exhibit 25: World Market for Ablation Electrophysiology Catheters Market Shareby Competitor, 2007
• Exhibit 26: World Market for Cardiac Angiography Catheters, 2003-2012, Revenues
• Exhibit 27: World Market for Cardiac Angiography Catheters, 2003-2012, Unit Sales
• Exhibit 28: World Market for Cardiac Angiography Catheters Market Share by Competitor, 2007
• Exhibit 29: World Market, Peripheral Vascular Angiography Catheters, Revenues 2003-2012
• Exhibit 30: World Market for Peripheral Vascular Angiography Catheters 2003-2012, Unit Sales
• Exhibit 31: World Market for Peripheral Vascular Angiography Catheters Market Share by Competitor, 2007
• Exhibit 32: World Market for Central Venous Catheters, Revenues, 2003-2012
• Exhibit 33: World Market for Central Venous Catheters, Unit Sales, 2003-2012
• Exhibit 34: World Market for Central Venous Catheters Market Share by Competitor, 2007
• Exhibit 35: World Market for Central Venous Catheters Market Share by Region (US, Europe, Japan, ROW)
• Exhibit 36: World Market for Peripheral Insertion Catheters, Revenues, 2003-2012
• Exhibit 37: World Market for Peripheral Insertion Catheters, Unit Sales, 2003-2012
• Exhibit 38: World Market for Peripheral Insertion Catheters Percentage of Revenues by Region, (US, Europe, Japan, ROW), 2007
• Exhibit 40: World Market for Peripherally Inserted Central Catheters, Revenues, 2003-2012
• Exhibit 41: World Market for Peripherally Inserted Central Catheters, Unit Sales 2003-2012
• Exhibit 42: World Market for Peripherally Inserted Central Catheters, Market Share by Competitor, 2007
• Exhibit 42: World Market for Peripheral Insertion Midline Catheters, Revenues 2003-2012
• Exhibit 43: World Market for Peripheral Insertion Midline Catheters: Unit Sales, 2003-2012
• Exhibit 44: World Market for Peripheral Insertion Midline Catheters Market Share by Competitor, 2007
• Exhibit 45: World Market for Wound Drainage Catheters, Revenues, 2003-2012
• Exhibit 46: World Market for Wound Drainage Catheters, Unit Sales, 2003-2012
• Exhibit 47: World Market for Wound Drainage Catheters Percentage of Revenues by Region (US, Europe, Japan, ROW), 2007
• Exhibit 48: World Market for Wound Drainage Catheters Market Share by Competitor, 2007
• Exhibit 49: World Market for Suction Catheters, Revenues 2003-2012
• Exhibit 50: World Market for Suction Catheters, Unit Sales, 2003-2012
• Exhibit 51: World Market for Suction Catheters Percentage of Revenues by Region (US, Europe, Japan, ROW), 2007
• Exhibit 52: World Market for Oximetry Catheters, Revenues, 2003-2012
• Exhibit 53: World Market for Oximetry Catheters , Revenues, 2003-2012
• Exhibit 54: World Market for Thermodilution Catheters, Revenues, 2003-2012
• Exhibit 55: World Market for Thermodilution Catheters, Unit Sales, 2003-2012
• Exhibit 56: World Market for Thermodilution Catheters Percentage of Revenues by Region, 2007